What is the first action in the management of suspected acute coronary syndrome with chest pain?

Prepare for the PNLE Nursing Practice I Test with targeted quizzes. Tackle multiple-choice questions designed to assess your nursing knowledge and skills. Equip yourself with the expertise needed to excel in your exam!

Multiple Choice

What is the first action in the management of suspected acute coronary syndrome with chest pain?

Explanation:
In suspected acute coronary syndrome with chest pain, the immediate goal is to stabilize the patient while rapidly identifying the type of ACS to guide urgent treatment. The first action is to assess airway, breathing, and circulation, and to keep the patient on continuous monitoring with IV access. A 12-lead ECG should be obtained as soon as possible, because it quickly distinguishes a STEMI from other ACS types and drives the urgency of reperfusion therapy. At the same time, administer aspirin as indicated (chewed if not contraindicated) because early platelet inhibition reduces mortality and improves outcomes. While preparing for definitive treatment, activate the rapid-response or STEMI protocol so the team can mobilize reperfusion resources without delay. Giving nitroglycerin or morphine before this initial evaluation can be risky: nitroglycerin may cause dangerous hypotension or be inappropriate in certain ACS contexts, and morphine’s benefit is uncertain with potential respiratory suppression and delays in definitive therapy. Keeping the focus on stabilization, rapid diagnosis, early antiplatelet therapy, and escalation of care explains why this sequence is the best first action.

In suspected acute coronary syndrome with chest pain, the immediate goal is to stabilize the patient while rapidly identifying the type of ACS to guide urgent treatment. The first action is to assess airway, breathing, and circulation, and to keep the patient on continuous monitoring with IV access. A 12-lead ECG should be obtained as soon as possible, because it quickly distinguishes a STEMI from other ACS types and drives the urgency of reperfusion therapy. At the same time, administer aspirin as indicated (chewed if not contraindicated) because early platelet inhibition reduces mortality and improves outcomes. While preparing for definitive treatment, activate the rapid-response or STEMI protocol so the team can mobilize reperfusion resources without delay.

Giving nitroglycerin or morphine before this initial evaluation can be risky: nitroglycerin may cause dangerous hypotension or be inappropriate in certain ACS contexts, and morphine’s benefit is uncertain with potential respiratory suppression and delays in definitive therapy. Keeping the focus on stabilization, rapid diagnosis, early antiplatelet therapy, and escalation of care explains why this sequence is the best first action.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy